EU medicines agencies reflect on lessons learned from COVID-19 – www.ema.europa.eu

1 Dic, 2023

www.ema.europa.eu
[ad_1]

The European Medicines Regulatory Network (EMRN) has been at the forefront of the fight against COVID-19 with its crucial role in the evaluation and monitoring of medicines, including vaccines. A joint report issued by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) reviews the Network’s response and highlights the main learnings for any future health crises.

[ad_2]

Vai all’articolo completo.